Wang Shyi-Chyi, Lai Hsing-Lin, Chiu Yi-Ting, Ou Ren, Huang Chuen-Lin, Chern Yijuang
Institute of Life Sciences, National Defence Medical Center, Taipei 104, Taiwan.
Biochem J. 2007 Sep 15;406(3):383-8. doi: 10.1042/BJ20070512.
In the present study, we demonstrate that AC5 (type V adenylate cyclase) interacts with Ric8a through directly interacting at its N-terminus. Ric8a was shown to be a GEF (guanine nucleotide exchange factor) for several alpha subunits of heterotrimeric GTP binding proteins (Galpha proteins) in vitro. Selective Galpha targets of Ric8a have not yet been revealed in vivo. An interaction between AC5 and Ric8a was verified by pull-down assays, co-immunoprecipitation analyses, and co-localization in the brain. Expression of Ric8a selectively suppressed AC5 activity. Treating cells with pertussis toxin or expressing a dominant negative Galphai mutant abolished the suppressive effect of Ric8a, suggesting that interaction between the N-terminus of AC5 and a GEF (Ric8a) provides a novel pathway to fine-tune AC5 activity via a Galphai-mediated pathway.
在本研究中,我们证明了AC5(V型腺苷酸环化酶)通过在其N端直接相互作用与Ric8a相互作用。在体外,Ric8a被证明是几种异源三聚体GTP结合蛋白(Gα蛋白)的α亚基的鸟嘌呤核苷酸交换因子(GEF)。Ric8a在体内的选择性Gα靶点尚未明确。通过下拉试验、免疫共沉淀分析和在脑中的共定位验证了AC5与Ric8a之间的相互作用。Ric8a的表达选择性地抑制了AC5的活性。用百日咳毒素处理细胞或表达显性负性Gαi突变体消除了Ric8a的抑制作用,这表明AC5的N端与GEF(Ric8a)之间的相互作用通过Gαi介导的途径提供了一种微调AC5活性的新途径。